Beam Therapeutics Inc.BEAMNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank75
3Y CAGR+7.2%
5Y CAGR+29.6%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+7.2%/yr
vs +64.9%/yr prior
5Y CAGR
+29.6%/yr
Recent deceleration
Acceleration
-57.7pp
Decelerating
Percentile
P75
Within normal range
vs 5Y Ago
3.7x
Strong expansion
Streak
2 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$108.15M-3.0%
2024$111.53M-4.5%
2023$116.81M+33.0%
2022$87.81M+53.4%
2021$57.22M+93.3%
2020$29.61M+44.0%
2019$20.55M+73.2%
2018$11.87M+438.3%
2017$2.20M-